Summary. External fixators (EF) are not commonly used for patients with haemophilia. We describe the use of EF (Ilizarov, AOβ uniβ and biβplanar fixators and Charnley clamp) in nine patients (mean age: 19.2βyears; range: 9β37) with haemophilia for the following indications β arthrodesis of infected joints, treatment of open fractures and osteoclasis. EF required an average of nine skin punctures [range: 4β17 were maintained for a period of 15βweeks (range: 8β29.5), without regular factor replacement, till bone healing was adequate and were removed with a single dose of factor infusion]. The mean preoperative factor level achieved was 85% (range: 64β102%). Much lower levels were subsequently maintained till wound healing. The average total factor consumption was 430βIUβkg^β1^ (range: 240β870), administered over a period of 17βdays (range: 9β44). There were no major complications related to EF except in a patient who developed inhibitors. In conclusion, EF can be used safely in haemophilic patients who do not have inhibitors and does not require prolonged factor replacement.